patients with inflammatory bowel disease
using lactulose and measuring antibodies to
lipid A. Gut Jun 1995;36(6):891–896
Welcker K, Martin A, Kölle P, Siebeck M,
Gross M. Increased intestinal permeability in
patients with inflammatory bowel disease.
Eur J Med Res 2004;9:456-460
Chronic diseases: Anja Sandek, et al. Altered
intestinal function in patients with chronic
heart failure. J Am Coll Cardiol Oct 2007;
50(16);1561-1569
Pradhan Aruna D, Manson JoAnn E, Rifai
Nader, et al. C-reactive protein, interleukin 6,
and risk of developing type 2 diabetes
mellitus. JAMA 2001;286(3):327-334
Cani Patrice D, et al. Metabolic endotoxemia
initiates obesity and insulin resistance.
Diabetes Jul 2007;56(7):1761-1772
Arrieta, M C, L Bistritz, J B Meddings.
Alterations in intestinal permeability. Gut